CLINICAL_TRIALS
trial_result
· 2021-10-07
Clinical Trial Update: A Phase 1 Study in Subjects With Relapsed or Refractory Multiple Myeloma [Phase 1]
Summary
Phase 1 study in subjects with relapsed or refractory multiple myeloma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Amgen | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED | Results posted: 2021-10-07